Parkinson's Disease Mechanisms and Treatments
Parkinson's Disease Mechanisms and Treatments is a research topic within Neurology. Science Explorer counts 55k research works in it since 1950. 26.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the pathophysiology, clinical features, diagnosis, genetic risk factors, and management of Parkinson's disease. It delves into the role of a-synuclein, neurodegeneration, dopaminergic neurons, oxidative stress, and mitochondrial dysfunction in the development and progression of the disease. Additionally, it discusses the non-motor symptoms and Lewy body pathology associated with Parkinson's disease.
- Parkinson's Disease
- a-Synuclein
- Neurodegeneration
- Dopaminergic Neurons
- Genetic Risk Factors
- Oxidative Stress
- Diagnostic Criteria
- Lewy Body Pathology
- Mitochondrial Dysfunction
- Non-motor Symptoms
- Research works
- 55k fractional, since 1950
- In the world top 10%
- 15k per year above
- Top-10% rate
- 26.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +26% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Parkinson's Disease Mechanisms and Treatments research?
By volume, the United States and China publish the most (2.2k and 1.7k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.2k works
- 2 China 1.7k works
- 3 India 761 works
- 4 Italy 560 works
- 5 United Kingdom 549 works
- 6 Germany 487 works
- 7 Japan 442 works
- 8 Brazil 339 works
- 9 South Korea 333 works
- 10 France 316 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Parkinson's Disease Mechanisms and Treatments research?
By volume in 2022–2025, University College London publishes the most Parkinson's Disease Mechanisms and Treatments research, followed by University of Florida and Capital Medical University.
By volume, 2022–2025
- 1 University College LondonUnited Kingdom 48 works
- 2 University of FloridaUnited States 45 works
- 3 Capital Medical UniversityChina 44 works
- 4 University of PennsylvaniaUnited States 38 works
- 5 Harvard UniversityUnited States 31 works
- 6 King's College LondonUnited Kingdom 31 works
- 7 German Center for Neurodegenerative DiseasesGermany 30 works
- 8 National Institute of Mental Health and NeurosciencesIndia 29 works
- 9 Sichuan UniversityChina 29 works
- 10 InsermFrance 29 works
Who are the leading researchers in Parkinson's Disease Mechanisms and Treatments?
The most-cited researchers publishing on Parkinson's Disease Mechanisms and Treatments include Dan J. Stein, Ettore Beghi and Perminder S. Sachdev.
- 1 Dan J. Stein South Africa 7.7k citations
- 2 Ettore Beghi Italy 4.6k citations
- 3 Perminder S. Sachdev Australia 4.6k citations
- 4 Seyed‐Mohammad Fereshtehnejad Sweden 4.2k citations
- 5 John Hardy United Kingdom 4k citations
- 6 Ronald C. Petersen United States 4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Parkinson's Disease Mechanisms and Treatments research done?
The largest centres of Parkinson's Disease Mechanisms and Treatments research in 2022–2025 are Beijing (China), London (United Kingdom), Seoul (South Korea) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Decorah.
Largest cities, 2022–2025
Where it is the local speciality
- DecorahUS · 24.3 works11×
Location quotient: how much more of its research is in Parkinson's Disease Mechanisms and Treatments than the world average.
Where is the best place to study Parkinson's Disease Mechanisms and Treatments?
Among universities, judged by research, University of Luxembourg, Medical University of Warsaw and University of Lübeck score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of LuxembourgLuxembourg | 55.1 | 58.9% | 3.7× | 9 | +207.8% |
| 2 | Medical University of WarsawPoland | 54.0 | 30.8% | 8.0× | 19 | +126.6% |
| 3 | University of LübeckGermany | 53.9 | 34.5% | 11.6× | 18 | -23.0% |
| 4 | Innsbruck Medical UniversityAustria | 53.1 | 33.1% | 15.5× | 15 | -12.2% |
| 5 | Capital Medical UniversityChina | 52.8 | 26.9% | 7.3× | 44 | +9.7% |
| 6 | Fujita Health UniversityJapan | 52.6 | 30.7% | 12.7× | 9 | +168.2% |
| 7 | University College LondonUnited Kingdom | 52.1 | 37.0% | 3.4× | 48 | +0.2% |
| 8 | Juntendo UniversityJapan | 51.1 | 16.6% | 15.7× | 25 | +32.1% |
| 9 | Radboud University NijmegenNetherlands | 49.0 | 40.2% | 5.2× | 23 | -6.1% |
| 10 | Karolinska InstitutetSweden | 48.2 | 29.0% | 5.1× | 23 | +17.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Parkinson's Disease Mechanisms and Treatments research growing?
Output in 2018–2022 was 26% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Parkinson's Disease Mechanisms and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.